RNA sequencing for research and diagnostics in clinical oncology

A Buzdin, M Sorokin, A Garazha, A Glusker… - Seminars in cancer …, 2020 - Elsevier
Molecular diagnostics is becoming one of the major drivers of personalized oncology. With
hundreds of different approved anticancer drugs and regimens of their administration …

Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications

N Shaban, D Kamashev, A Emelianova, A Buzdin - Cells, 2023 - mdpi.com
Members of the EGFR family of tyrosine kinase receptors are major regulators of cellular
proliferation, differentiation, and survival. In humans, abnormal activation of EGFR is …

Algorithmic annotation of functional roles for components of 3,044 human molecular pathways

M Sorokin, N Borisov, D Kuzmin, A Gudkov… - Frontiers in …, 2021 - frontiersin.org
Current methods of high-throughput molecular and genomic analyses enabled to
reconstruct thousands of human molecular pathways. Knowledge of molecular pathways …

Intratumoral heterogeneity and longitudinal changes in gene expression predict differential drug sensitivity in newly diagnosed and recurrent glioblastoma

EL Kim, M Sorokin, SR Kantelhardt, D Kalasauskas… - Cancers, 2020 - mdpi.com
Background: Inevitable recurrence after radiochemotherapy is the major problem in the
treatment of glioblastoma, the most prevalent type of adult brain malignancy. Glioblastomas …

RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer

M Sorokin, E Poddubskaya… - Molecular …, 2020 - molecularcasestudies.cshlp.org
Gastric cancer (GC) is the fifth-ranked cancer type by associated mortality. The proportion of
early diagnosis is low, and most patients are diagnosed at the advanced stages. First-line …

Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new …

A Modestov, M Zolotovskaia… - … in medical oncology, 2024 - journals.sagepub.com
Background: Glioblastoma (GBM) is the most aggressive and lethal central nervous system
(CNS) tumor. The treatment strategy is mainly surgery and/or radiation therapy, both …

Transcriptomic harmonization as the way for suppressing cross-platform bias and batch effect

N Borisov, A Buzdin - Biomedicines, 2022 - mdpi.com
(1) Background: Emergence of methods interrogating gene expression at high throughput
gave birth to quantitative transcriptomics, but also posed a question of inter-comparison of …

Using proteomic and transcriptomic data to assess activation of intracellular molecular pathways

A Buzdin, V Tkachev, M Zolotovskaia, A Garazha… - Advances in protein …, 2021 - Elsevier
Abstract Analysis of molecular pathway activation is the recent instrument that helps to
quantize activities of various intracellular signaling, structural, DNA synthesis and repair …

Uniformly shaped harmonization combines human transcriptomic data from different platforms while retaining their biological properties and differential gene …

N Borisov, V Tkachev, A Simonov, M Sorokin… - Frontiers in Molecular …, 2023 - frontiersin.org
Introduction: Co-normalization of RNA profiles obtained using different experimental
platforms and protocols opens avenue for comprehensive comparison of relevant features …

Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data

M Sorokin, M Zolotovskaia, D Nikitin, M Suntsova… - BMC cancer, 2022 - Springer
Background: Overall survival of advanced colorectal cancer (CRC) patients remains poor,
and gene expression analysis could potentially complement detection of clinically relevant …